8Owen C, Marks DJ, Banks M. The dangers of proton pump inhibitor therapy [ J ]. Br J Hosp Med (Lond) , 2014,75 ( 7 ) : C108-112.
9Brunner-Ziegler S, Jilma B, Magirr D, et al. Influence of protonpump inhibitors and VKORC1 mutations on CYP'2Cg- mediated dose requirements of vitamin K antagonist therapy : a pilot study [ J ]. Br J Haematol, 2014, 167 (4) : 547-553. DOI : 10. 1111/bib. 13082.
2BezC, PerrottetN, ZinggT, et al. Stress ulcer prophylaxis in non-critically ill patients:a prospective evaluation of current practice in a generalsurgery department[J]. J Eval Clin Pract, 2013, 19(2):374-378. DOI: 10.1111/j.1365-2753.2012.01838.x.
3AlqudahMA, Al-AzzamS, AlzoubiK, et al. Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan[J]. Int J Clin Pharmacol Ther, 2016, 54(8):597-602. DOI: 10.5414/CP202533.
4BardouM, QuenotJP, BarkunA. Stress-related mucosal disease in the critically ill patient[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(2):98-107. DOI: 10.1038/nrgastro.2014.235.
5BarkunAN, BardouM, PhamCQ, et al. Proton Pump Inhibitors vs. Histamine 2 Receptor Antagonists for Stress-Related Mucosal Bleeding Prophylaxis in Critically Ill Patients: A Meta-Analysis[J]. Am J Gastroenterol, 2012, 107(4):507-520. DOI: 10.1038/ajg.2011.474.
6BarkunAN, AdamV, MartelM, et al. Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists[J]. Value Health, 2013, 16(1):14-22. DOI: 10.1016/j.jval.2012.08.2213.
7EomCS, JeonCY, LimJW, et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review andmeta-analysis[J]. CMAJ, 2011, 183(3):310. DOI: 10.1503/cmaj.092129.
9SarzynskiE, PuttarajappaC, XieY, et al. Association between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study[J]. Dig Dis Sci, 2011, 56(8):2349-2353. DOI: 10.1007/s10620-011-1589-y.
10RoY, EunCS, KimHS, et al. Risk of Clostridium difficile Infection with the use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically III patients[J]. Gut Liver, 2016, 10(4):581-586. DOI: 10.5009/gnl15324.
